Aug 30 |
Data I/O And 2 Other Stocks Under $5 Executives Are Buying
|
Aug 28 |
ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements
|
Aug 28 |
ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements
|
Aug 22 |
ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript
|
Aug 22 |
Endra Life Sciences GAAP EPS of -$0.08 misses by $0.01
|
Aug 22 |
ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update
|
Aug 21 |
Endra Life Sciences Q2 2024 Earnings Preview
|
Aug 16 |
ENDRA Life Sciences Announces Reverse Stock Split
|
Aug 13 |
ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024
|
Aug 13 |
ENDRA Life Sciences appoints Alexander Tokman as acting CEO
|